TEVA-SPIRONOLACTONE/HCTZ
TEVA-SPIRONOLACTONE/HCTZ
Approved
DIN Number
00613231
Drug Class
Human
Market Date
Dec 31, 1984
Company
HC
teva canada limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00613231
AIG Number0201064001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C03EA01 HYDROCHLOROTHIAZIDE AND POTASSIUM-SPARING AGENTS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:32.20
Health Canada Classification
ACTIVE INGREDIENTS (2)
HYDROCHLOROTHIAZIDEActive
Strength: 25 MG
Monograph: HYDROCHLOROTHIAZIDE
SPIRONOLACTONEActive
Strength: 25 MG
Monograph: SPIRONOLACTONE